Navigation Links
Need for Change in Social Norms to Prevent Spread of HIV

The global AIDS epidemic has touched the 25 year mark and this year has been heralded as the “least bad” year yet. With increasing// access to lifesaving treatments last year even in developing countries , a few hard-hit countries have reported declining HIV infection rates. However Bill Gates addressing the International AIDS Conference in Toronto this week said that current trends don’t bode well for the future because estimates have shown that for each person who started anti-HIV therapy last year, 10 more contracted the virus.

Gates noted, “When you extrapolate five to 10 years, you quickly see that there is no feasible way to … treat everyone …. unless we dramatically reduce the number of new infections.”

According to Dr. Helene Gayle, the president and CEO of CARE, a humanitarian organization, and co-chair of the International AIDS Conference, in spite of funding from international sources to about $8 billion this year she proposes that the spread of HIV has not met with success mainly because of the shift of focus from prevention to treatment of the disease. She states that much is needed to be done to integrate better prevention and treatment.

Without that failure was certain. In addition she stated the need for better coordination of prevention, testing, treatment and counseling to stop the disease..

When questioned about the results of prevention methods of the past 25 years she said, ‘HIV rates have decreased in countries like Uganda and Thailand and now in some countries in eastern and southern Africa. When people enroll in trials to test microbicides [topical agents that may prevent HIV transmission] or preventive drug therapies, their rate of HIV transmission often drops because they receive intensive preventive counselling, access to condoms and treatment for their other sexually transmitted diseases. This may explain why the first microbicide trial, done several years ago, couldn’t detect a difference betw
'"/>




Page: 1 2 3

Related medicine news :

1. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
2. Change in walking might indicate Dementia
3. Change in weight not a risk in healthy men
4. Changes in cabin pressure pose risks for moms-to-be
5. Dietary Changes Could Reduce The Risk for Stroke
6. Link Between High Blood Sugar And Behavioral Changes
7. Improving Lighting Could Bring About A Change In Alzheimers Patients
8. Specific Changes In A Particular Gene Found To Increase The Risk of Alzheimer’s Diseas
9. Impotence Drugs Ordered by FDA to have Label Change
10. Ultrasounds To Detect Changes In Heart Motions
11. Change In Diet May Slow The Progression Of Prostate Cancer
Post Your Comments:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
...nts and innerwear with net inserts are some of the...rs are experimenting with.Overall, the trend in li... and forms with a hint of romance. The seductive u... self-restraint. "There's a lot being tried with e...
... overcrowding of farm owners in local veterinary c...ility of a bird flu outbreak in Tamil Nadub //. Th...as first reported in the month of February. More ...in Manakkad area of Salem district, 400 km south o...
...asing their emotional pain by taking Oxycontin, a ...ful dose they turn to heroin as a cheaper option. ...on of American children getting addicted to prescr...nting with legal drugs like OxyContin, (hillbilly ...
...ent of prosthetic limbs researchers at University ... muscles which are powered by alcohol and hydrogen...uscles are 100 times more powerful than the body's... being investigated by US researchers at the Nanot...
Other Medicine News:Health News:Romantic and discreet trends in lingerie 2Health News:New Generation Teenagers Addiction to Prescription Drugs 2
(Date:10/10/2008)... SWARTZ CREEK, Mich., Oct. 10 /- D...va Neuroscience has selected Diplomat,Specialty Ph...e in a large,scale, national Therapy Optimization ... of the two year TOP MS study, is to examine the b... program on compliance, adherence and,patient outc...
(Date:10/10/2008)... PLEASANTON, Calif., Oct. 10 /- Tr...as been authorized to affix the CE (Conformite,Eur...ntares(TM) Coronary,Stent System, a unique main ve... near coronary bifurcations., Representing the ne...(TM) system has potential use in a quarter of the ...
(Date:10/9/2008)... Top Line Clinical Results Expected in November...ll/ -- SCOLR Pharma, Inc.,(Amex: DDD ) announced ...ing,for the third of its three pivotal trials to e... of 12-hour extended-release (ER) ibuprofen for,th...ts to report top-line,results from this pivotal tr...
(Date:10/8/2008)... Acceptance Will Reduce Animal Use in Cosmetics...RNewswire/ -- MatTek Corp. today announced,that re...i-laboratory,"catch-up" validation study on MatTek...The test results demonstrated the required sensiti... a validated alternative to animal,testing for det...
Breaking Medicine Technology:Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Muscular Dystrophy Treatment Shows Promise 6450 1Muscular Dystrophy Treatment Shows Promise 6450 2Muscular Dystrophy Treatment Shows Promise 6450 3Granger wins Schmidt Nielsen Mentor Scientist Award 1243 1Granger wins Schmidt Nielsen Mentor Scientist Award 1243 2USP announces 11 new proposed monographs for dietary supplements 6444 1USP announces 11 new proposed monographs for dietary supplements 6444 2Medical Services Gets Significant Interest in Its Dual VScan Test Kit 6440 1Medical Services Gets Significant Interest in Its Dual VScan Test Kit 6440 2
...cer drug developer Antisoma plc,(LSE: ASM, US OTC:... trial of ASA404 in recurrent, platinum-sensitive ...ving ASA404 plus chemotherapy,(n=37) with patients...dings are as follows: , * There was no advantage i...arm compared with the control arm * One-year survi...
...RNewswire-FirstCall/ -- ImClone,Systems Incorporat...d results from an open-label Phase III study of ER... in the first-line,treatment for metastatic non-sm...et its primary endpoint of progression-free,surviv...eview,committee (IRRC). However, key secondary end...
Other Medicine Technology:Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial 2Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial 3Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 2Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 3Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 4Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 5Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 6Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 7Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 8Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 9
The Bio-Quant TROPONIN I test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of cardiac,troponin I (cTnI) in human serum specimens as an aid i
...or many patients with a diseased heart, the only t...t transplant. However, donor organs are not always...le die while they are on the waiting list for a do... devices (VAD) can save the life of a patient. On ...
...nstaTest AFP is an immunochromatographic in vitro ...n human serum. AFP is a protein with molecular mas...entration in serum is below 9 ng/mL; higher concen... testicular and presacral teratocarcinomas, and ot...
STA Compact is a fully automated random access coagulation analyser for clotting, photometric and immunological, latex based .coagulation tests.The medium-throughput analyser offers continous loading
Medicine Products: